B-59
NCT03281954
JBG-1801
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Status:
Recruiting
III
Phase
Neoajduvant
Line of Therapy
Disease Stage
Biomarker(s)
TNBC
Investigational
Product
Atezolizumab
Treatment Arms
o Placebo
o Atezolizumab